About the Authors
- John C. Castle
-
Contributed equally to this work with: John C. Castle, Yoshikazu Hara
* E-mail: john_castle@merck.com (JCC); jason_johnson@merck.com (JMJ)
Affiliation Rosetta Inpharmatics LLC, Seattle, Washington, United States of America
- Yoshikazu Hara
-
Contributed equally to this work with: John C. Castle, Yoshikazu Hara
Affiliation Metabolic Disorder Research, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
- Christopher K. Raymond
-
Affiliation Rosetta Inpharmatics LLC, Seattle, Washington, United States of America
- Philip Garrett-Engele
-
Affiliation Rosetta Inpharmatics LLC, Seattle, Washington, United States of America
- Kenji Ohwaki
-
Affiliation Metabolic Disorder Research, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
- Zhengyan Kan
-
Affiliation Rosetta Inpharmatics LLC, Seattle, Washington, United States of America
- Jun Kusunoki
-
Affiliation Metabolic Disorder Research, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
- Jason M. Johnson
-
* E-mail: john_castle@merck.com (JCC); jason_johnson@merck.com (JMJ)
Affiliation Rosetta Inpharmatics LLC, Seattle, Washington, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: JC CR KO JK JMJ. Performed the experiments: YH CR PGE KO. Analyzed the data: JC YH CR KO ZK. Contributed reagents/materials/analysis tools: JC CR PGE KO. Wrote the paper: JC CR KO JK JMJ.